Table 1 Primary and secondary outcomes of the study
Outcome | Metric | Time point |
|---|---|---|
Primary | ||
 Atherosclerosis | Occurrence rate of atherosclerosis | 36 months |
Secondary | ||
 The combined cardiovascular events | Incidence | 36 months |
 All-cause mortality | Incidence | 36 months |
 eGFR decreased by 50% | the proportion of eGFR decreased by 50% | 36 months |
 Safety outcomes | Numbers | 36 months |